The CDC originally applied for EUA status for the RT-PCR test for COVID-19 in February 2020. Since then, it has proved to be notoriously unreliable and has largely been discredited as a diagnostic tool to detect the COVID-19 virus. The test will be outlawed on January 1, 2022.

However, when reading the details on the CDC website, a strong smell of rotting fish fills the room.

First, the test was never granted full FDA approval. Instead, it was permitted for use under the Emergency Use Authorization (EUA). In other words, it was an experimental diagnostic tool.

And yet, it was used to drive the entire nation into the Great Panic that literally turned our society upside down.

Second, the Lab Alert directs clinicians to "Visit the FDA website for a list of authorized COVID-19 diagnostic methods."

According to the FDA's own rules, no EUA can be granted for an experimental drug/treatment if an approved solution already exists. Furthermore, if an EUA is in play for one drug and another drug is approved for the same application, then the EUA on the experimental drug is immediately removed.